Jerusalem: Israel has started the trial of giving the fourth dose of vaccine to protect against Covid-19. It is believed to be the first study of its kind. At Shiba Medical Center on the outskirts of the capital Tel Aviv, trials began on 150 medical workers who received a booster (third) dose in August, being given the fourth dose of the Pfizer/Biontech vaccine.
The additional doses given to the personnel were tested and found to have low levels of antibodies in their bodies. The trial has started at a time when Israeli officials are considering giving the country’s population a second booster dose (fourth dose) as infections from the Omicron form continue to grow out of the country.
“Hopefully we will be able to prove that the fourth dose actually provides protection against Omicron and is much needed,” said Professor Jacob LaVey, former director of the Department of Cardiovascular Transplantation at the Shiba Medical Center.
